207940:KRXSamsung Biologics Co.,Ltd. Analysis
Data as of 2026-09-08 - not real-time
₩1,440,000.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Samsung Biologics Co.,Ltd. trades at KRW 1,440,000.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 6.8%. Relative strength is 41.4 — neutral — and the MACD signal is bearish. Watch KRW 1,433,000.00 as support and KRW 1,645,000.00 as the nearer resistance level.
Multiples put this in undervalued territory: 29.3 times earnings against the sector's 30.6. Consensus targets land 36.6% above where the shares trade now. Revenue is growing at 30.2% on a 38.7% profit margin.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 39.8%, a beta of 0.01 and a maximum drawdown of 36.7%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.
Multiples put this in undervalued territory: 29.3 times earnings against the sector's 30.6. Consensus targets land 36.6% above where the shares trade now. Revenue is growing at 30.2% on a 38.7% profit margin.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 39.8%, a beta of 0.01 and a maximum drawdown of 36.7%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.
Top Market Events
Updated Jul 22, 2026 0 - Recorded Q2'26 revenue of KRW 1,321 billion and operating profit of KRW 586 billion -...media 1147690 Recorded Q2'26 revenue of KRW 1,321 billion and operating profit of KRW 586 billionDelivered stable...SEOUL dpa-AFX - PolyPeptide Group AG PPGN.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 1576404.94
- MACD momentum is negative
- 30-day price change of -6.8%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 29.3 versus sector average of 30.6
- Trading below the 200-day average of 1576404.94
- Analyst targets imply +36.6% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 29.3 versus sector average of 30.6
- Analyst targets imply +36.6% versus the current price
- Profit margin of 38.7% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth30.20%
Profit Margin38.75%
P/E Ratio29.3
ROE18.53%
ROA9.57%
Debt/Equity14.84
Op. Cash Flow₩2433.9B
Free Cash Flow₩1295.2B
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI41.4
Support₩1,433,000.00
Resistance₩1,645,000.00
MA 20₩1,533,800.00
MA 50₩1,476,360.00
MA 200₩1,576,404.94
MACDBearish
VolumeStable
Fear & Greed Index94.11
Valuation
Fair Value₩986,467.16
Target Price₩1,967,520.00
Upside/Downside36.63%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.01
Volatility39.76%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.